Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot

from feed/http://bit.ly/1sYYZLQ at http://bit.ly/2UkJY85 on March 29, 2019 at 04:30PM

Transparency as a principle of good governance is not the same as transparency for improving access by lowering prices. In fact, the former often carries an opportunity cost on the latter. Developing country markets are, however, dominated by generic products and encouraging competition through sharing prices makes sense if capacities are there to use the data to inform procurement decisions and protect against collusion.